Clinical Trials Browser

Colonic Neoplasms, Rectal Neoplasms

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Liver Metastases From Colorectal Cancer (mCRC)

Ependymoma, Medulloblastoma, Recurrence

Pancreatic Cancer Metastatic

Carcinoma, Hepatocellular

Colorectal Neoplasms

Neuroblastoma

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Colonic Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Rhabdomyosarcoma

Colorectal Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Carcinoma, Pancreatic Neoplasms

Lung Neoplasms

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

Neuroblastoma

BRAF V600 Colorectal Cancer

Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Esophageal Squamous Cell Carcinoma

Colorectal Neoplasms

Biliary Cancer Metastatic

Colorectal Neoplasms

Pancreatic Neoplasms

Neuroblastoma

Locally Advanced Rectal Cancer

Colorectal Cancer Metastatic

Colonic Neoplasms

Breast Cancer Metastatic

Neoplasms, Second Primary

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

Rectal Neoplasms

Colorectal Neoplasms

Carcinoma, Neuroendocrine

Pancreatic Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Stomach Neoplasms

Colorectal Neoplasms

Clinical Trials

SCOTI

I-SPY

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

PANCREAS

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

MEMMAT

PASS-01

AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC

ERASE-CRC

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

PANC

A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation

Pancreas

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

CEIL

VICTORIA

Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

GRACIE

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer

A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer

Second-line Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Fruquintinib Versus Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Bevacizumab in Metastatic Colorectal Cancer

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer

Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM

Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas

OPTICAL-2

mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line

HERBIC

Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma

Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma

ShorTrip

FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients

Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer

Phenomenal

FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC

Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer

Short-course Radiotherapy or Long-course Chemoradiation Followed by MFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer

NIVACOR

SENECA

PIOPPO

Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab

FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer

AVETRIC